Medical Condition News

RSS
Study reveals promising new drug candidate to treat acute renal failure

Study reveals promising new drug candidate to treat acute renal failure

Immediate compression therapy could cut risk of complications after deep-vein thrombosis

Immediate compression therapy could cut risk of complications after deep-vein thrombosis

Grieving patients treated with talk therapy have lower risk of suicide and psychiatric illness

Grieving patients treated with talk therapy have lower risk of suicide and psychiatric illness

Brain region for stress control is enlarged in people with depression, finds study

Brain region for stress control is enlarged in people with depression, finds study

First evaluation of benefits, harms of Alzheimer's screening for family members of older adults

First evaluation of benefits, harms of Alzheimer's screening for family members of older adults

Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes

Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes

CWRU receives NIH grant to learn how non-coding genes contribute to spread of colorectal cancer

CWRU receives NIH grant to learn how non-coding genes contribute to spread of colorectal cancer

New type of fatty acid can slow down overreactive immune system

New type of fatty acid can slow down overreactive immune system

Finding epigenetic signature appears to predict inflammation risk in serious type of IBD

Finding epigenetic signature appears to predict inflammation risk in serious type of IBD

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

New program to reduce harmful stress effectively improves mood in cancer patients

New program to reduce harmful stress effectively improves mood in cancer patients

Chaos and agitation: Helping a patient survive a hurricane

Chaos and agitation: Helping a patient survive a hurricane

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Survey: 91% of people around the world believe medical research will result in dementia cure

Survey: 91% of people around the world believe medical research will result in dementia cure

Inflammation plays crucial role in preventing heart attacks and strokes, study reveals

Inflammation plays crucial role in preventing heart attacks and strokes, study reveals

First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval

First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

UK and European research collaborations receive vote of confidence by three major cancer charities

UK and European research collaborations receive vote of confidence by three major cancer charities

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.